Peripheral Drug Eluting Balloons Market - Global Peripheral Drug Eluting Balloons Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 -

Description

The Global market for peripheral drug-eluting balloons (DEBs) is poised for substantial expansion, with forecasts indicating significant growth by the year 2031. Recent market research projects the peripheral DEB market to reach a value of US$1800 million by 2031, marking a remarkable surge from the US$950 million recorded in 2024. This growth trajectory underscores the increasing demand for innovative medical solutions, driven by various factors such as technological advancements, the rising prevalence of Peripheral Artery Disease (PAD), and a notable shift towards minimally invasive procedures.

Key Growth Determinants

Advancements in Cardiovascular Treatment: Ongoing advancements in cardiovascular treatment have led to an increased adoption of minimally invasive procedures, including peripheral DEBs. These balloons offer a targeted approach to treating PAD by delivering drugs directly to the affected area, thereby enhancing efficacy and reducing restenosis rates compared to traditional balloons or stents.

Growing Prevalence of Peripheral Artery Disease: The rising prevalence of peripheral artery disease, primarily due to aging populations and lifestyle factors, is propelling the demand for innovative treatment options like DEBs. As the incidence of PAD continues to rise Globally, there is a corresponding increase in the need for effective and durable treatment solutions, thereby fueling the growth of the peripheral DEB market.

Shift Towards Minimally Invasive Procedures: Patients and healthcare providers are increasingly preferring minimally invasive procedures over traditional surgical interventions due to benefits such as shorter recovery times, reduced risk of complications, and improved patient outcomes. Peripheral DEBs align with this trend, offering a less invasive alternative for treating PAD compared to surgical options like bypass surgery. This shift towards minimally invasive procedures is expected to contribute significantly to the expansion of the peripheral DEB market.

Major Growth Barriers

Regulatory Hurdles: The market faces stringent regulatory requirements, which can slow down the approval process for new products or expansions into different regions. Compliance with varying regulations across different countries adds complexity and can delay market entry.

Limited Clinical Evidence: Despite their potential benefits, there's still a lack of extensive clinical data supporting the efficacy and safety of peripheral DEBs compared to traditional treatments. This limits physician confidence and adoption, particularly in regions where reimbursement may be tied to demonstrated clinical outcomes.

Cost Constraints: Peripheral DEBs are often priced higher than conventional treatment options such as plain balloons or stents. This cost discrepancy can pose a barrier to adoption, especially in healthcare systems where cost-effectiveness is a major consideration. Reimbursement policies may not fully cover the higher costs associated with DEBs, leading to reluctance from healthcare providers to utilize these devices, particularly in cost-sensitive environments.

Key Trends and Opportunities to Look at

Digital Health Integration: The healthcare industry is increasingly embracing digital technologies to enhance patient care and streamline processes. In the medical device sector, there's a noticeable trend towards integrating digital health features into products. Peripheral drug-eluting balloons (PDEBs) with digital monitoring capabilities could provide real-time data on drug release and patient response, enabling healthcare providers to adjust treatment strategies accordingly.

Focus on Minimally Invasive Procedures: There's a significant shift towards minimally invasive procedures across various medical specialties, including cardiovascular interventions. Patients prefer minimally invasive techniques due to shorter recovery times, reduced risk of complications, and better cosmetic outcomes. PDEBs offer a less invasive alternative to traditional treatment methods for peripheral artery disease (PAD) and other vascular conditions. As the preference for minimally invasive procedures continues to grow, the demand for innovative devices like PDEBs is expected to rise.

Expansion into Emerging Markets: One of the significant opportunities for PDEB manufacturers is expanding their presence in emerging markets. Developing countries are witnessing a rise in the prevalence of cardiovascular diseases due to lifestyle changes, urbanization, and an aging population. However, access to advanced medical treatments remains limited in these regions. By tapping into emerging markets, PDEB manufacturers can address unmet medical needs, drive revenue growth, and establish themselves as key players in the Global healthcare landscape.

Regional Frontrunners

1.North America Leads Innovations in Peripheral DEB Market: North America dominates the Global peripheral DEB market due to factors such as high healthcare expenditure, advanced healthcare infrastructure, and early adoption of innovative medical technologies. The region has a substantial patient population suffering from PAD, particularly in the elderly demographic.
2.Europe Experiences Robust Growth and Advancements in Minimally Invasive Procedures: Europe is another significant market for peripheral DEBs, fueled by the increasing incidence of PAD and the growing preference for minimally invasive procedures. Countries like Germany, the UK, and France lead the market, supported by well-established healthcare systems and a robust network of healthcare facilities.
3.Asia Pacific Emerges as a High-Potential Market: The Asia Pacific region exhibits immense growth potential in the Peripheral DEB market, attributed to the rising geriatric population, changing lifestyle patterns, and improving healthcare infrastructure. Countries like China, India, and Japan are key contributors to market growth, driven by large patient pools and increasing healthcare expenditure.

Competitive analysis:

Abbott Laboratories
Boston Scientific Corporation
Cook Medical Inc.
MicroPort Scientific Corporation (Endovastec(TM))
Medtronic Plc.
Cardinal Health, Inc.
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
W. L. Gore & Associates Inc.
Getinge AB
Terumo Corp
Kyoto Medical Planning Co Ltd
iVascular S.L.U
AMG International GmbH
ENDOCOR GmbH
Meril Life Sciences Pvt. Ltd.
Nano Therapeutics Pvt Ltd
Koninklijke Philips N.V.
REVA Medical

The Global Peripheral Drug Eluting Balloons Market is Segmented as Below:

Drug Coating:

Paclitaxel Drug Coating
Sirolimus drug Coating
Others

Indication:

Peripheral Arterial Disease
Peripheral Aneurysms
In-Stent Restenosis
Others

Artery Type:

Carotid Arteries
Fem-Pop Arteries
Iliac Arteries
Infrapop Arteries

End User:

Hospitals
Ambulatory Surgical Centres/Outpatients
Cardiac Catheterization Labs

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Peripheral Drug Eluting Balloons Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Peripheral Drug Eluting Balloons Market Outlook, 2019 - 2031

3.1. Global Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Paclitaxel Drug Coating
  - 3.1.1.2. Sirolimus Drug Coating
  - 3.1.1.3. Others
3.2. Global Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Peripheral Arterial Disease
  - 3.2.1.2. Peripheral Aneurysms
  - 3.2.1.3. In Stent Restenosis
  - 3.2.1.4. Others
3.3. Global Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Carotid Arteries
  - 3.3.1.2. Fem-Pop Arteries
  - 3.3.1.3. Illiac Arteries
  - 3.3.1.4. Infrapop Arteries
3.4. Global Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Hospitals
  - 3.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 3.4.1.3. Cardiac Catheterization Labs
3.5. Global Peripheral Drug Eluting Balloons Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Peripheral Drug Eluting Balloons Market Outlook, 2019 - 2031

4.1. North America Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Paclitaxel Drug Coating
  - 4.1.1.2. Sirolimus Drug Coating
  - 4.1.1.3. Others
4.2. North America Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Peripheral Arterial Disease
  - 4.2.1.2. Peripheral Aneurysms
  - 4.2.1.3. In Stent Restenosis
  - 4.2.1.4. Others
4.3. North America Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Carotid Arteries
  - 4.3.1.2. Fem-Pop Arteries
  - 4.3.1.3. Illiac Arteries
  - 4.3.1.4. Infrapop Arteries
4.4. North America Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Hospitals
  - 4.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 4.4.1.3. Cardiac Catheterization Labs
4.5. North America Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 4.5.1.2. U.S. Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 4.5.1.3. U.S. Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 4.5.1.4. U.S. Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 4.5.1.5. Canada Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 4.5.1.6. Canada Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 4.5.1.7. Canada Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 4.5.1.8. Canada Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Peripheral Drug Eluting Balloons Market Outlook, 2019 - 2031

5.1. Europe Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Paclitaxel Drug Coating
  - 5.1.1.2. Sirolimus Drug Coating
  - 5.1.1.3. Others
5.2. Europe Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Peripheral Arterial Disease
  - 5.2.1.2. Peripheral Aneurysms
  - 5.2.1.3. In Stent Restenosis
  - 5.2.1.4. Others
5.3. Europe Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Carotid Arteries
  - 5.3.1.2. Fem-Pop Arteries
  - 5.3.1.3. Illiac Arteries
  - 5.3.1.4. Infrapop Arteries
5.4. Europe Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals
  - 5.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 5.4.1.3. Cardiac Catheterization Labs
5.5. Europe Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.2. Germany Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.3. Germany Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.4. Germany Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.5. U.K. Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.6. U.K. Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.7. U.K. Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.8. U.K. Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.9. France Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.10. France Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.11. France Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.12. France Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.13. Italy Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.14. Italy Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.15. Italy Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.16. Italy Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.17. Turkey Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.18. Turkey Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.19. Turkey Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.20. Turkey Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.21. Russia Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.22. Russia Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.23. Russia Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.24. Russia Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.25. Rest of Europe Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.26. Rest of Europe Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.27. Rest of Europe Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 5.5.1.28. Rest of Europe Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, 2019 - 2031

6.1. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Paclitaxel Drug Coating
  - 6.1.1.2. Sirolimus Drug Coating
  - 6.1.1.3. Others
6.2. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Peripheral Arterial Disease
  - 6.2.1.2. Peripheral Aneurysms
  - 6.2.1.3. In Stent Restenosis
  - 6.2.1.4. Others
6.3. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Carotid Arteries
  - 6.3.1.2. Fem-Pop Arteries
  - 6.3.1.3. Illiac Arteries
  - 6.3.1.4. Infrapop Arteries
6.4. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Hospitals
  - 6.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 6.4.1.3. Cardiac Catheterization Labs
6.5. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.2. China Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.3. China Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.4. China Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.5. Japan Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.6. Japan Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.7. Japan Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.8. Japan Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.9. South Korea Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.10. South Korea Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.11. South Korea Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.12. South Korea Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.13. India Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.14. India Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.15. India Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.16. India Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.17. Southeast Asia Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.18. Southeast Asia Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.19. Southeast Asia Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.20. Southeast Asia Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.21. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.22. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.23. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 6.5.1.24. Rest of Asia Pacific Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Peripheral Drug Eluting Balloons Market Outlook, 2019 - 2031

7.1. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Paclitaxel Drug Coating
  - 7.1.1.2. Sirolimus Drug Coating
  - 7.1.1.3. Others
7.2. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Peripheral Arterial Disease
  - 7.2.1.2. Peripheral Aneurysms
  - 7.2.1.3. In Stent Restenosis
  - 7.2.1.4. Others
7.3. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Carotid Arteries
  - 7.3.1.2. Fem-Pop Arteries
  - 7.3.1.3. Illiac Arteries
  - 7.3.1.4. Infrapop Arteries
7.4. Latin America Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals
  - 7.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 7.4.1.3. Cardiac Catheterization Labs
7.5. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.2. Brazil Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.3. Brazil Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.4. Brazil Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.5. Mexico Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.6. Mexico Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.7. Mexico Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.8. Mexico Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.9. Argentina Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.10. Argentina Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.11. Argentina Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.12. Argentina Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.13. Rest of Latin America Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.14. Rest of Latin America Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.15. Rest of Latin America Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 7.5.1.16. Rest of Latin America Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, 2019 - 2031

8.1. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Paclitaxel Drug Coating
  - 8.1.1.2. Sirolimus Drug Coating
  - 8.1.1.3. Others
8.2. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Peripheral Arterial Disease
  - 8.2.1.2. Peripheral Aneurysms
  - 8.2.1.3. In Stent Restenosis
  - 8.2.1.4. Others
8.3. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Carotid Arteries
  - 8.3.1.2. Fem-Pop Arteries
  - 8.3.1.3. Illiac Arteries
  - 8.3.1.4. Infrapop Arteries
8.4. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals
  - 8.4.1.2. Ambulatory Surgical Centers / Outpatients
  - 8.4.1.3. Cardiac Catheterization Labs
8.5. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.2. GCC Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.3. GCC Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.4. GCC Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.5. South Africa Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.6. South Africa Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.7. South Africa Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.8. South Africa Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.9. Egypt Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.10. Egypt Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.11. Egypt Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.12. Egypt Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.13. Nigeria Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.14. Nigeria Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.15. Nigeria Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.16. Nigeria Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market by Drug Coating, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market Indication, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market Artery Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Peripheral Drug Eluting Balloons Market End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Artery Type vs Indication Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Abbott Laboratories
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Boston Scientific Corporation
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Cook Medical Inc.
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Microport Scientific Corporation
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Medtronic Plc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Cardinal Health Inc.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. B. Braun Melsungen AG
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. BIOTRONIK SE & CO. KG
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Becton, Dickinson and Company
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. W.L. Gore & Associates Co. Ltd.
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Getinge AB
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Terumo Corp
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. iVascular S.L.U
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Kyoto Medical Planning Co Ltd
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. AMG International GmbH
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development
- 9.5.16. Endocor GmbH
  - 9.5.16.1. Company Overview
  - 9.5.16.2. Product Portfolio
  - 9.5.16.3. Financial Overview
  - 9.5.16.4. Business Strategies and Development
- 9.5.17. Meril Life Sciences Pvt. Ltd.
  - 9.5.17.1. Company Overview
  - 9.5.17.2. Product Portfolio
  - 9.5.17.3. Financial Overview
  - 9.5.17.4. Business Strategies and Development
- 9.5.18. Nano Therapeutics Pvt. Ltd.
  - 9.5.18.1. Company Overview
  - 9.5.18.2. Product Portfolio
  - 9.5.18.3. Financial Overview
  - 9.5.18.4. Business Strategies and Development
- 9.5.19. Koninklijke Philips N.V.
  - 9.5.19.1. Company Overview
  - 9.5.19.2. Product Portfolio
  - 9.5.19.3. Financial Overview
  - 9.5.19.4. Business Strategies and Development
- 9.5.20. Reva Medical
  - 9.5.20.1. Company Overview
  - 9.5.20.2. Product Portfolio
  - 9.5.20.3. Financial Overview
  - 9.5.20.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations